These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 31101936)

  • 21. Insights into the antiviral activity of phospholipases A
    Teixeira SC; Borges BC; Oliveira VQ; Carregosa LS; Bastos LA; Santos IA; Jardim ACG; Melo FF; Freitas LM; Rodrigues VM; Lopes DS
    Int J Biol Macromol; 2020 Dec; 164():616-625. PubMed ID: 32698062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel bioactive peptides demonstrating anti-dengue virus activity isolated from the Asian medicinal plant Acacia Catechu.
    Panya A; Yongpitakwattana P; Budchart P; Sawasdee N; Krobthong S; Paemanee A; Roytrakul S; Rattanabunyong S; Choowongkomon K; Yenchitsomanus PT
    Chem Biol Drug Des; 2019 Feb; 93(2):100-109. PubMed ID: 30225997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial peptides for novel antiviral strategies in the current post-COVID-19 pandemic.
    Loffredo MR; Nencioni L; Mangoni ML; Casciaro B
    J Pept Sci; 2024 Jan; 30(1):e3534. PubMed ID: 37501572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phage display of combinatorial peptide libraries: application to antiviral research.
    Castel G; Chtéoui M; Heyd B; Tordo N
    Molecules; 2011 Apr; 16(5):3499-518. PubMed ID: 21522083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Basic chemokine-derived glycosaminoglycan binding peptides exert antiviral properties against dengue virus serotype 2, herpes simplex virus-1 and respiratory syncytial virus.
    Vanheule V; Vervaeke P; Mortier A; Noppen S; Gouwy M; Snoeck R; Andrei G; Van Damme J; Liekens S; Proost P
    Biochem Pharmacol; 2016 Jan; 100():73-85. PubMed ID: 26551597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emerging paradigms of viral diseases and paramount role of natural resources as antiviral agents.
    Sagaya Jansi R; Khusro A; Agastian P; Alfarhan A; Al-Dhabi NA; Arasu MV; Rajagopal R; Barcelo D; Al-Tamimi A
    Sci Total Environ; 2021 Mar; 759():143539. PubMed ID: 33234268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dengue structural proteins as antiviral drug targets: Current status in the drug discovery & development.
    S AH; Pujar GV; Sethu AK; Bhagyalalitha M; Singh M
    Eur J Med Chem; 2021 Oct; 221():113527. PubMed ID: 34020338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent Patents and FDA-Approved Drugs Based on Antiviral Peptides and Other Peptide-Related Antivirals.
    Mousavi Maleki MS; Sardari S; Ghandehari Alavijeh A; Madanchi H
    Int J Pept Res Ther; 2023; 29(1):5. PubMed ID: 36466430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Model membrane platforms for biomedicine: case study on antiviral drug development.
    Jackman JA; Cho NJ
    Biointerphases; 2012 Dec; 7(1-4):18. PubMed ID: 22589061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plant-Derived Antimicrobial Peptides as Potential Antiviral Agents in Systemic Viral Infections.
    Mammari N; Krier Y; Albert Q; Devocelle M; Varbanov M; On Behalf Of The Oemonom
    Pharmaceuticals (Basel); 2021 Aug; 14(8):. PubMed ID: 34451871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiviral Peptides Targeting the Helicase Activity of Enterovirus Nonstructural Protein 2C.
    Fang Y; Wang C; Wang C; Yang R; Bai P; Zhang XY; Kong J; Yin L; Qiu Y; Zhou X
    J Virol; 2021 May; 95(12):. PubMed ID: 33789997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A review of the antiviral activity of cationic antimicrobial peptides.
    Urmi UL; Vijay AK; Kuppusamy R; Islam S; Willcox MDP
    Peptides; 2023 Aug; 166():171024. PubMed ID: 37172781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Labyrinthopeptin A1 inhibits dengue and Zika virus infection by interfering with the viral phospholipid membrane.
    Oeyen M; Meyen E; Noppen S; Claes S; Doijen J; Vermeire K; Süssmuth RD; Schols D
    Virology; 2021 Oct; 562():74-86. PubMed ID: 34274562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of brevinin-1EMa-derived stapled peptides as broad-spectrum virus entry blockers.
    Kim MI; Pham TK; Kim D; Park M; Kim BO; Cho YH; Kim YW; Lee C
    Virology; 2021 Sep; 561():6-16. PubMed ID: 34089997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-dengue virus serotype 2 activity and mode of action of a novel peptide.
    Chew MF; Tham HW; Rajik M; Sharifah SH
    J Appl Microbiol; 2015 Oct; 119(4):1170-80. PubMed ID: 26248692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioactive Natural Antivirals: An Updated Review of the Available Plants and Isolated Molecules.
    Mohan S; Elhassan Taha MM; Makeen HA; Alhazmi HA; Al Bratty M; Sultana S; Ahsan W; Najmi A; Khalid A
    Molecules; 2020 Oct; 25(21):. PubMed ID: 33105694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural antimicrobial peptides as a source of new antiviral agents.
    Zakaryan H; Chilingaryan G; Arabyan E; Serobian A; Wang G
    J Gen Virol; 2021 Sep; 102(9):. PubMed ID: 34554085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strategies to identify and develop antiviral peptides.
    Poh CL; Lalani S
    Vitam Horm; 2021; 117():17-46. PubMed ID: 34420580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthetic Frog-Derived-like Peptides: A New Weapon against Emerging and Potential Zoonotic Viruses.
    Chianese A; Iovane V; Zannella C; Capasso C; Nastri BM; Monti A; Doti N; Montagnaro S; Pagnini U; Iovane G; De Filippis A; Galdiero M
    Viruses; 2023 Aug; 15(9):. PubMed ID: 37766211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A mastoparan-derived peptide has broad-spectrum antiviral activity against enveloped viruses.
    Sample CJ; Hudak KE; Barefoot BE; Koci MD; Wanyonyi MS; Abraham S; Staats HF; Ramsburg EA
    Peptides; 2013 Oct; 48():96-105. PubMed ID: 23891650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.